Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model

Background: Thousands of babies are born with congenital heart defects that require surgical repair involving a prosthetic implant. Lack of growth in prosthetic grafts is especially detrimental in pediatric surgery. Cell seeded biodegradable tissue engineered grafts are a novel solution to this problem. The purpose of the present study is to evaluate the feasibility of seeding human induced pluripotent stem cell derived cardiomyocytes ( hiPS-CMs) onto a biodegradable cardiac patch. Methods: The hiPS-CMs were cultured on a biodegradable patch composed of a polyglycolic acid ( PGA) and a 50: 50 poly ( l-lactic-co-epsilon-caprolactone) copolymer ( PLCL) for 1 week. Male athymic rats were randomly divided into 2 groups of 10 animals each: 1. hiPS-CM seeded group, and 2. Unseeded group. After culture, the cardiac patch was implanted to repair a defect with a diameter of 2 mm created in the right ventricular outflow tract ( RVOT) wall. Hearts were explanted at 4 ( n = 2), 8 ( n = 2), and 16 ( n = 6) weeks after patch implantation. Explanted patches were assessed immunohistochemically. Results: Seeded patch explants did not stain positive for alpha-actinin ( marker of cardiomyocytes) at the 4 week time point, suggesting that the cultured hiPS-CMs evacuated the patch in the early phase of tissue remodeling. However, after 16 weeks implantation, the area fraction of positively stained alpha-actinin cells was significantly higher in the seeded group than in the unseeded group ( Seeded group: 6.1 +/- 2.8% vs. Unseeded group: 0.95 +/- 0.50%, p = 0.004), suggesting cell seeding promoted regenerative proliferation of host cardiomyocytes. Conclusions: Seeded hiPS-CMs were not present in the patch after 4 weeks. However, we surmise that they influenced the regeneration of host cardiomyocytes via a paracrine mechanism. Tissue-engineered hiPS-CMs seeded cardiac patches warrant further investigation for use in the repair of congenital heart diseases.